Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lipocine (LPCN) Interest Coverage Ratio (2018 - 2022)

Historic Interest Coverage Ratio for Lipocine (LPCN) over the last 5 years, with Q2 2022 value amounting to 466.11.

  • Lipocine's Interest Coverage Ratio fell 79516.21% to 466.11 in Q2 2022 from the same period last year, while for Mar 2023 it was 1760.88, marking a year-over-year decrease of 875971.66%. This contributed to the annual value of 447.24 for FY2022, which is 299050.13% down from last year.
  • As of Q2 2022, Lipocine's Interest Coverage Ratio stood at 466.11, which was down 79516.21% from 160.36 recorded in Q1 2022.
  • Lipocine's Interest Coverage Ratio's 5-year high stood at 398.86 during Q4 2021, with a 5-year trough of 466.11 in Q2 2022.
  • For the 5-year period, Lipocine's Interest Coverage Ratio averaged around 41.5, with its median value being 34.47 (2020).
  • Its Interest Coverage Ratio has fluctuated over the past 5 years, first skyrocketed by 77395.09% in 2021, then plummeted by 79516.21% in 2022.
  • Lipocine's Interest Coverage Ratio (Quarter) stood at 10.77 in 2018, then tumbled by 106.81% to 22.26 in 2019, then tumbled by 165.82% to 59.18 in 2020, then surged by 773.95% to 398.86 in 2021, then crashed by 216.86% to 466.11 in 2022.
  • Its Interest Coverage Ratio was 466.11 in Q2 2022, compared to 160.36 in Q1 2022 and 398.86 in Q4 2021.